Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies

Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variabili...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2016-08, Vol.117, p.154-161
Hauptverfasser: Matte, Darlan L, Pizzichini, Marcia M.M, Hoepers, Andrea T.C, Diaz, Alexandre P, Karloh, Manuela, Dias, Mirella, Pizzichini, Emilio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 161
container_issue
container_start_page 154
container_title Respiratory medicine
container_volume 117
creator Matte, Darlan L
Pizzichini, Marcia M.M
Hoepers, Andrea T.C
Diaz, Alexandre P
Karloh, Manuela
Dias, Mirella
Pizzichini, Emilio
description Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size >100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.
doi_str_mv 10.1016/j.rmed.2016.06.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1809608593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0954611116301305</els_id><sourcerecordid>1809608593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoMo7tnVP-CFBLzxpsfJR9NWRFjO-gULu6BeSkjTKeTYNsdMq5x_b8rZRdgLYWACed6BeYaxFwK2AoR5s9-mEbutzO8t5ALziG1EqWShwOjHbANNqQsjhDhj50R7AGi0hqfsTFa6kaU0G_bjNuFvN-Dkkceed3hISBTixMPEdze3V2_5JacjzTi6OXie6YB_uJs6PuLsCje54UiB1rCP05ziMGDHaV66gPSMPendQPj8rl-w7x8_fNt9Lq5vPn3ZXV4XvtTNXLjKKd2Dd9CLtm4r07W6qk2FvvK6Vq0XqmlNnXsptHeu0XVljHS18r5VyqkL9vo095DirwVptmMgj8PgJowLWVFDY6AuG5XRVw_QfVxS3uJESWFq2WRKniifIlHC3h5SGF06WgF2lW_3dpVvV_kWcoHJoZd3o5d2_buP3NvOwLsTgNlF9pgs-bCq70JCP9suhv_Pf_8g7ocwBe-Gn3hE-reHJWnBfl3Pv15fGAVCQan-Ah9RqdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1809216829</pqid></control><display><type>article</type><title>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Matte, Darlan L ; Pizzichini, Marcia M.M ; Hoepers, Andrea T.C ; Diaz, Alexandre P ; Karloh, Manuela ; Dias, Mirella ; Pizzichini, Emilio</creator><creatorcontrib>Matte, Darlan L ; Pizzichini, Marcia M.M ; Hoepers, Andrea T.C ; Diaz, Alexandre P ; Karloh, Manuela ; Dias, Mirella ; Pizzichini, Emilio</creatorcontrib><description>Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size &gt;100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2016.06.006</identifier><identifier>PMID: 27492526</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age ; Aged ; Chronic obstructive pulmonary disease ; Comorbidity ; COPD ; Depression ; Depression - complications ; Depression - epidemiology ; Depression - etiology ; Female ; Hospitals ; Humans ; Male ; Mental depression ; Meta-analysis ; Middle Aged ; Mortality ; Population ; Prevalence ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - psychology ; Pulmonary/Respiratory ; Quality ; Review ; Severity of Illness Index ; Smoking - epidemiology ; Spirometry ; Studies ; Systematic review</subject><ispartof>Respiratory medicine, 2016-08, Vol.117, p.154-161</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 01, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</citedby><cites>FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0954611116301305$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27492526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matte, Darlan L</creatorcontrib><creatorcontrib>Pizzichini, Marcia M.M</creatorcontrib><creatorcontrib>Hoepers, Andrea T.C</creatorcontrib><creatorcontrib>Diaz, Alexandre P</creatorcontrib><creatorcontrib>Karloh, Manuela</creatorcontrib><creatorcontrib>Dias, Mirella</creatorcontrib><creatorcontrib>Pizzichini, Emilio</creatorcontrib><title>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size &gt;100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.</description><subject>Age</subject><subject>Aged</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>COPD</subject><subject>Depression</subject><subject>Depression - complications</subject><subject>Depression - epidemiology</subject><subject>Depression - etiology</subject><subject>Female</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Male</subject><subject>Mental depression</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Population</subject><subject>Prevalence</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - psychology</subject><subject>Pulmonary/Respiratory</subject><subject>Quality</subject><subject>Review</subject><subject>Severity of Illness Index</subject><subject>Smoking - epidemiology</subject><subject>Spirometry</subject><subject>Studies</subject><subject>Systematic review</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1TAQhoMo7tnVP-CFBLzxpsfJR9NWRFjO-gULu6BeSkjTKeTYNsdMq5x_b8rZRdgLYWACed6BeYaxFwK2AoR5s9-mEbutzO8t5ALziG1EqWShwOjHbANNqQsjhDhj50R7AGi0hqfsTFa6kaU0G_bjNuFvN-Dkkceed3hISBTixMPEdze3V2_5JacjzTi6OXie6YB_uJs6PuLsCje54UiB1rCP05ziMGDHaV66gPSMPendQPj8rl-w7x8_fNt9Lq5vPn3ZXV4XvtTNXLjKKd2Dd9CLtm4r07W6qk2FvvK6Vq0XqmlNnXsptHeu0XVljHS18r5VyqkL9vo095DirwVptmMgj8PgJowLWVFDY6AuG5XRVw_QfVxS3uJESWFq2WRKniifIlHC3h5SGF06WgF2lW_3dpVvV_kWcoHJoZd3o5d2_buP3NvOwLsTgNlF9pgs-bCq70JCP9suhv_Pf_8g7ocwBe-Gn3hE-reHJWnBfl3Pv15fGAVCQan-Ah9RqdA</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Matte, Darlan L</creator><creator>Pizzichini, Marcia M.M</creator><creator>Hoepers, Andrea T.C</creator><creator>Diaz, Alexandre P</creator><creator>Karloh, Manuela</creator><creator>Dias, Mirella</creator><creator>Pizzichini, Emilio</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20160801</creationdate><title>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</title><author>Matte, Darlan L ; Pizzichini, Marcia M.M ; Hoepers, Andrea T.C ; Diaz, Alexandre P ; Karloh, Manuela ; Dias, Mirella ; Pizzichini, Emilio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Age</topic><topic>Aged</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>COPD</topic><topic>Depression</topic><topic>Depression - complications</topic><topic>Depression - epidemiology</topic><topic>Depression - etiology</topic><topic>Female</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Male</topic><topic>Mental depression</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Population</topic><topic>Prevalence</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - psychology</topic><topic>Pulmonary/Respiratory</topic><topic>Quality</topic><topic>Review</topic><topic>Severity of Illness Index</topic><topic>Smoking - epidemiology</topic><topic>Spirometry</topic><topic>Studies</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matte, Darlan L</creatorcontrib><creatorcontrib>Pizzichini, Marcia M.M</creatorcontrib><creatorcontrib>Hoepers, Andrea T.C</creatorcontrib><creatorcontrib>Diaz, Alexandre P</creatorcontrib><creatorcontrib>Karloh, Manuela</creatorcontrib><creatorcontrib>Dias, Mirella</creatorcontrib><creatorcontrib>Pizzichini, Emilio</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matte, Darlan L</au><au>Pizzichini, Marcia M.M</au><au>Hoepers, Andrea T.C</au><au>Diaz, Alexandre P</au><au>Karloh, Manuela</au><au>Dias, Mirella</au><au>Pizzichini, Emilio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>117</volume><spage>154</spage><epage>161</epage><pages>154-161</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size &gt;100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27492526</pmid><doi>10.1016/j.rmed.2016.06.006</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2016-08, Vol.117, p.154-161
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_miscellaneous_1809608593
source MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Age
Aged
Chronic obstructive pulmonary disease
Comorbidity
COPD
Depression
Depression - complications
Depression - epidemiology
Depression - etiology
Female
Hospitals
Humans
Male
Mental depression
Meta-analysis
Middle Aged
Mortality
Population
Prevalence
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - epidemiology
Pulmonary Disease, Chronic Obstructive - physiopathology
Pulmonary Disease, Chronic Obstructive - psychology
Pulmonary/Respiratory
Quality
Review
Severity of Illness Index
Smoking - epidemiology
Spirometry
Studies
Systematic review
title Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A35%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20depression%20in%20COPD:%20A%20systematic%20review%20and%20meta-analysis%20of%20controlled%20studies&rft.jtitle=Respiratory%20medicine&rft.au=Matte,%20Darlan%20L&rft.date=2016-08-01&rft.volume=117&rft.spage=154&rft.epage=161&rft.pages=154-161&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2016.06.006&rft_dat=%3Cproquest_cross%3E1809608593%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1809216829&rft_id=info:pmid/27492526&rft_els_id=1_s2_0_S0954611116301305&rfr_iscdi=true